应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ARGX Argenx SE
盘后交易 08-14 17:17:10 EDT
652.43
+5.83
+0.90%
盘后
665.35
+12.92
+1.98%
16:35 EDT
最高
654.00
最低
644.63
成交量
22.10万
今开
646.60
昨收
646.60
日振幅
1.45%
总市值
399.29亿
流通市值
399.08亿
总股本
6,120万
成交额
1.44亿
换手率
0.36%
流通股本
6,117万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Argenx Se8月11日成交额为4.25亿美元
市场透视 · 08-12 01:18
Argenx Se8月11日成交额为4.25亿美元
Argenx Se8月8日成交额为1.88亿美元
市场透视 · 08-09
Argenx Se8月8日成交额为1.88亿美元
Argenx Se2025财年第二财季实现净利润4.18亿美元,同比增加1386.95%
市场透视 · 08-08
Argenx Se2025财年第二财季实现净利润4.18亿美元,同比增加1386.95%
Argenx Se8月6日成交额为2.77亿美元
市场透视 · 08-07
Argenx Se8月6日成交额为2.77亿美元
Argenx Se8月5日成交额为3.26亿美元
市场透视 · 08-06
Argenx Se8月5日成交额为3.26亿美元
Argenx Se8月4日成交额为2.81亿美元
市场透视 · 08-05
Argenx Se8月4日成交额为2.81亿美元
Argenx Se8月1日成交额为4.26亿美元
市场透视 · 08-02
Argenx Se8月1日成交额为4.26亿美元
Argenx Se涨13.04% 股价突破600美元大关
市场透视 · 07-31
Argenx Se涨13.04% 股价突破600美元大关
Argenx Se7月29日成交额为1.57亿美元
市场透视 · 07-30
Argenx Se7月29日成交额为1.57亿美元
Argenx Se7月28日成交额为2.21亿美元
市场透视 · 07-29
Argenx Se7月28日成交额为2.21亿美元
Argenx Se7月25日成交额为2.92亿美元
市场透视 · 07-26
Argenx Se7月25日成交额为2.92亿美元
Argenx Se7月23日成交额为1.59亿美元
市场透视 · 07-24
Argenx Se7月23日成交额为1.59亿美元
Argenx Se7月22日成交额为1.28亿美元
市场透视 · 07-23
Argenx Se7月22日成交额为1.28亿美元
Argenx Se7月21日成交额为1.16亿美元
市场透视 · 07-22
Argenx Se7月21日成交额为1.16亿美元
Argenx Se7月17日成交额为2.57亿美元
市场透视 · 07-18
Argenx Se7月17日成交额为2.57亿美元
Argenx Se7月16日成交额为2.66亿美元
市场透视 · 07-17
Argenx Se7月16日成交额为2.66亿美元
Argenx Se7月14日成交额为2.01亿美元
市场透视 · 07-15
Argenx Se7月14日成交额为2.01亿美元
Argenx Se7月10日成交额为2.05亿美元
市场透视 · 07-11
Argenx Se7月10日成交额为2.05亿美元
Argenx Se7月9日成交额为3.68亿美元
市场透视 · 07-10
Argenx Se7月9日成交额为3.68亿美元
Argenx Se7月8日成交额为2.56亿美元
市场透视 · 07-09
Argenx Se7月8日成交额为2.56亿美元
加载更多
公司概况
公司名称:
Argenx SE
所属市场:
NASDAQ
上市日期:
--
主营业务:
Argenx Se根据荷兰法律于2008年4月25日成立,是一家私人有限责任公司(besloten vennootschap met beperkte aansprakelijkheid)。 于2014年5月28日,根据公证转换契约及修订,该公司转为上市有限责任公司(naamloze vennootschap)。 该公司是一家处于商业阶段的、全球性的、完全整合的生物制药公司,开发用于治疗严重自身免疫性疾病的差异化疗法。
发行价格:
--
{"stockData":{"symbol":"ARGX","market":"US","secType":"STK","nameCN":"Argenx SE","latestPrice":652.43,"timestamp":1755201600000,"preClose":646.6,"halted":0,"volume":220972,"hourTrading":{"tag":"盘后","latestPrice":665.35,"preClose":652.43,"latestTime":"16:35 EDT","volume":5461,"amount":3562972.87404,"timestamp":1755203734055},"delay":0,"floatShares":61167949,"shares":61199902,"eps":18.748034,"marketStatus":"盘后交易","change":5.83,"latestTime":"08-14 17:17:10 EDT","open":646.6,"high":654,"low":644.63,"amount":143519667.7586,"amplitude":0.014491,"askPrice":665.35,"askSize":1,"bidPrice":641,"bidSize":1,"shortable":3,"etf":0,"ttmEps":18.748034,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1755216000000},"marketStatusCode":4,"adr":1,"adrRate":1,"listingDate":1495080000000,"exchange":"NASDAQ","adjPreClose":646.6,"preHourTrading":{"tag":"盘前","latestPrice":647.05,"preClose":646.6,"latestTime":"09:22 EDT","volume":657,"amount":427837.12542000005,"timestamp":1755177760643},"postHourTrading":{"tag":"盘后","latestPrice":665.35,"preClose":652.43,"latestTime":"16:35 EDT","volume":5461,"amount":3562972.87404,"timestamp":1755203734055},"volumeRatio":0.495092,"impliedVol":0.2805,"impliedVolPercentile":0.108},"requestUrl":"/m/hq/s/ARGX","defaultTab":"news","newsList":[{"id":"2558917536","title":"Argenx Se8月11日成交额为4.25亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558917536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558917536?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:18","pubTimestamp":1754961500,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日,Argenx Se成交额为4.25亿美元,成交额较昨日增加125.83%,当日成交量为66.25万股。Argenx Se于2025年8月11日跌3.46%,报638.9美元,该股过去5个交易日跌7.45%,年初至今涨3.89%,过去60日涨20.03%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091832a482e303&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091832a482e303&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","IE00B2B36J28.USD","BK4505","BK4139","IE0002141913.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4585","IE00BJT1NW94.SGD","BK4588","LU0320765992.SGD","ARGX","LU0109394709.USD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2558508707","title":"Argenx Se8月8日成交额为1.88亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558508707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558508707?lang=zh_cn&edition=full","pubTime":"2025-08-09 09:18","pubTimestamp":1754702305,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日,Argenx Se成交额为1.88亿美元,成交额较昨日减少15.90%,当日成交量为28.37万股。Argenx Se于2025年8月8日跌1.56%,报661.83美元,该股过去5个交易日跌1.78%,年初至今涨7.61%,过去60日涨22.0%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809091837a47e1c51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809091837a47e1c51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4588","IE00BFTCPJ56.SGD","BK4139","LU0320765992.SGD","ARGX","IE00BJJMRZ35.SGD","BK4585","LU0889565916.HKD","IE0009355771.USD","BK4505","IE0002141913.USD"],"gpt_icon":0},{"id":"2558575425","title":"Argenx Se2025财年第二财季实现净利润4.18亿美元,同比增加1386.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558575425","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558575425?lang=zh_cn&edition=full","pubTime":"2025-08-09 00:00","pubTimestamp":1754668827,"startTime":"0","endTime":"0","summary":"8月9日,Argenx Se公布财报,公告显示公司2025财年第二财季净利润为4.18亿美元,同比增加1386.95%;其中营业收入为17.53亿美元,同比增加99.89%,每股基本收益为6.85美元。从资产负债表来看,Argenx Se总负债10.80亿美元,其中短期债务7.58百万美元,资产负债比为6.65,流动比率为5.60。机构评级:截至2025年8月9日,当前有32家机构对Argenx Se目标价做出预测,其中目标均价为805.07美元,其中最低目标价为700.00美元,最高目标价为1070.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809000034a6db5589&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809000034a6db5589&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARGX"],"gpt_icon":0},{"id":"2557581446","title":"Argenx Se8月6日成交额为2.77亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557581446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557581446?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:18","pubTimestamp":1754529505,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日,Argenx Se成交额为2.77亿美元,成交额较昨日减少14.97%,当日成交量为41.08万股。Argenx Se于2025年8月6日跌0.26%,报673.15美元,该股过去5个交易日涨12.4%,年初至今涨9.46%,过去60日涨22.47%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807091827a6d78e9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807091827a6d78e9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARGX","BK4585","BK4505","LU0889565916.HKD","BK4588","BK4139","LU0109394709.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2557345798","title":"Argenx Se8月5日成交额为3.26亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557345798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557345798?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:18","pubTimestamp":1754443089,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日,Argenx Se成交额为3.26亿美元,成交额较昨日增加16.07%,当日成交量为47.63万股。Argenx Se于2025年8月5日跌2.23%,报674.9美元,该股过去5个交易日涨12.71%,年初至今涨9.74%,过去60日涨18.59%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806091812a4778a4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806091812a4778a4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","BK4585","BK4505","BK4588","ARGX"],"gpt_icon":0},{"id":"2557356590","title":"Argenx Se8月4日成交额为2.81亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557356590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557356590?lang=zh_cn&edition=full","pubTime":"2025-08-05 09:18","pubTimestamp":1754356683,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日,Argenx Se成交额为2.81亿美元,成交额较昨日减少34.11%,当日成交量为41.10万股。Argenx Se于2025年8月4日涨2.45%,报690.32美元,该股过去5个交易日涨15.98%,年初至今涨12.25%,过去60日涨10.82%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805091809a4756520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805091809a4756520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","ARGX","BK4588","BK4585","BK4505","BK4139","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2556484478","title":"Argenx Se8月1日成交额为4.26亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556484478","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556484478?lang=zh_cn&edition=full","pubTime":"2025-08-02 09:17","pubTimestamp":1754097473,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日,Argenx Se成交额为4.26亿美元,成交额较昨日减少54.27%,当日成交量为63.36万股。Argenx Se于2025年8月1日涨0.52%,报673.8美元,该股过去5个交易日涨13.82%,年初至今涨9.56%,过去60日涨9.54%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802091755a6ce9d78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802091755a6ce9d78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4588","ARGX","LU0320765992.SGD","BK4585","BK4139","BK4505","LU0889565916.HKD"],"gpt_icon":0},{"id":"2555836637","title":"Argenx Se涨13.04% 股价突破600美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2555836637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555836637?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:31","pubTimestamp":1753968679,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时31分,Argenx Se股票出现异动,股价快速上涨13.04%。Argenx Se股票所在的生物技术行业中,整体涨幅为1.33%。Argenx Se公司简介:Argenx是一家荷兰生物制药公司,专注于开发针对罕见自身免疫性疾病的基于抗体的疗法。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213119a6cbc9c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213119a6cbc9c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARGX","BK4585","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","BK4505","BK4139","BK4588"],"gpt_icon":0},{"id":"2555098994","title":"Argenx Se7月29日成交额为1.57亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555098994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555098994?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:18","pubTimestamp":1753838324,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日,Argenx Se成交额为1.57亿美元,成交额较昨日减少28.77%,当日成交量为26.37万股。Argenx Se于2025年7月29日涨0.6%,报598.79美元,该股过去5个交易日涨4.82%,年初至今跌2.64%,过去60日跌6.42%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730091856a46a7acf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730091856a46a7acf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0109394709.USD","LU0320765992.SGD","BK4139","LU0889565916.HKD","BK4585","BK4505","ARGX"],"gpt_icon":0},{"id":"2555088366","title":"Argenx Se7月28日成交额为2.21亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555088366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555088366?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:18","pubTimestamp":1753751894,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日,Argenx Se成交额为2.21亿美元,成交额较昨日减少24.24%,当日成交量为37.11万股。Argenx Se于2025年7月28日涨0.54%,报595.19美元,该股过去5个交易日涨5.13%,年初至今跌3.22%,过去60日跌7.74%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729091820a4688b94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729091820a4688b94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0109394709.USD","LU0889565916.HKD","BK4588","LU0320765992.SGD","BK4505","BK4585","ARGX"],"gpt_icon":0},{"id":"2554790466","title":"Argenx Se7月25日成交额为2.92亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554790466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554790466?lang=zh_cn&edition=full","pubTime":"2025-07-26 09:18","pubTimestamp":1753492713,"startTime":"0","endTime":"0","summary":"美东时间2025年7月25日,Argenx Se成交额为2.92亿美元,成交额较昨日增加31.92%,当日成交量为49.31万股。Argenx Se于2025年7月25日涨0.04%,报591.99美元,该股过去5个交易日涨4.85%,年初至今跌3.74%,过去60日跌5.96%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726091844a46416ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726091844a46416ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ARGX","LU0889565916.HKD","BK4505","LU0109394709.USD","BK4139","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2553221215","title":"Argenx Se7月23日成交额为1.59亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553221215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553221215?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:18","pubTimestamp":1753319880,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日,Argenx Se成交额为1.59亿美元,成交额较昨日增加24.09%,当日成交量为27.82万股。Argenx Se于2025年7月23日涨0.73%,报575.42美元,该股过去5个交易日跌0.43%,年初至今跌6.44%,过去60日跌6.4%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724091810a6be7cfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724091810a6be7cfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4588","ARGX","LU0320765992.SGD","BK4585","BK4139","BK4505","LU0889565916.HKD"],"gpt_icon":0},{"id":"2553262434","title":"Argenx Se7月22日成交额为1.28亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553262434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553262434?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:17","pubTimestamp":1753233464,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日,Argenx Se成交额为1.28亿美元,成交额较昨日增加10.94%,当日成交量为22.47万股。Argenx Se于2025年7月22日涨0.9%,报571.23美元,该股过去5个交易日涨2.75%,年初至今跌7.12%,过去60日跌4.88%。该公司的主要产品Vyvgart 于2021年12月获得FDA批准,用于治疗广泛性重症肌无力。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723091750a6bc011e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723091750a6bc011e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ARGX","BK4505","LU0320765992.SGD","LU0889565916.HKD","BK4139","BK4588","LU0109394709.USD"],"gpt_icon":0},{"id":"2553400916","title":"Argenx Se7月21日成交额为1.16亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553400916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553400916?lang=zh_cn&edition=full","pubTime":"2025-07-22 09:17","pubTimestamp":1753147056,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日,Argenx Se成交额为1.16亿美元,成交额较昨日减少39.53%,当日成交量为20.45万股。Argenx Se于2025年7月21日涨0.27%,报566.14美元,该股过去5个交易日涨0.87%,年初至今跌7.94%,过去60日跌4.79%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722091746a6b96159&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722091746a6b96159&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4505","ARGX","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","BK4585"],"gpt_icon":0},{"id":"2552458325","title":"Argenx Se7月17日成交额为2.57亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552458325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552458325?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:17","pubTimestamp":1752801459,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日,Argenx Se成交额为2.57亿美元,成交额较昨日减少3.55%,当日成交量为45.11万股。Argenx Se于2025年7月17日跌0.9%,报572.71美元,该股过去5个交易日涨1.67%,年初至今跌6.88%,过去60日跌3.86%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718091742a6b0d3ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718091742a6b0d3ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARGX","BK4588","BK4585","LU0889565916.HKD","BK4505","LU0320765992.SGD","LU0109394709.USD","BK4139"],"gpt_icon":0},{"id":"2552171679","title":"Argenx Se7月16日成交额为2.66亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552171679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552171679?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:17","pubTimestamp":1752715055,"startTime":"0","endTime":"0","summary":"美东时间2025年7月16日,Argenx Se成交额为2.66亿美元,成交额较昨日增加35.94%,当日成交量为46.47万股。Argenx Se于2025年7月16日涨3.95%,报577.92美元,该股过去5个交易日涨4.09%,年初至今跌6.03%,过去60日跌3.07%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717091746a6ae79cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717091746a6ae79cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0320765992.SGD","BK4139","BK4505","LU0889565916.HKD","LU0109394709.USD","BK4585","ARGX"],"gpt_icon":0},{"id":"2551101134","title":"Argenx Se7月14日成交额为2.01亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551101134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551101134?lang=zh_cn&edition=full","pubTime":"2025-07-15 09:18","pubTimestamp":1752542295,"startTime":"0","endTime":"0","summary":"美东时间2025年7月14日,Argenx Se成交额为2.01亿美元,成交额较昨日增加44.75%,当日成交量为35.63万股。Argenx Se于2025年7月14日涨0.19%,报561.28美元,该股过去5个交易日涨2.79%,年初至今跌8.73%,过去60日跌7.28%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715091822a6a9ceb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715091822a6a9ceb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4585","LU0320765992.SGD","ARGX","BK4588","LU0109394709.USD","LU0889565916.HKD","BK4139"],"gpt_icon":0},{"id":"2550608427","title":"Argenx Se7月10日成交额为2.05亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550608427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550608427?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:18","pubTimestamp":1752196686,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日,Argenx Se成交额为2.05亿美元,成交额较昨日减少44.21%,当日成交量为36.43万股。Argenx Se于2025年7月10日涨1.46%,报563.31美元,该股过去5个交易日涨3.34%,年初至今跌8.4%,过去60日跌3.03%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091815a4438a80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091815a4438a80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","LU0109394709.USD","LU0320765992.SGD","BK4505","BK4585","LU0889565916.HKD","ARGX"],"gpt_icon":0},{"id":"2550660486","title":"Argenx Se7月9日成交额为3.68亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550660486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550660486?lang=zh_cn&edition=full","pubTime":"2025-07-10 09:17","pubTimestamp":1752110255,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日,Argenx Se成交额为3.68亿美元,成交额较昨日增加44.04%,当日成交量为67.13万股。Argenx Se于2025年7月9日涨3.07%,报555.19美元,该股过去5个交易日涨2.34%,年初至今跌9.73%,过去60日涨1.64%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710091747a6a064b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710091747a6a064b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","ARGX","BK4585","BK4505"],"gpt_icon":0},{"id":"2550451577","title":"Argenx Se7月8日成交额为2.56亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550451577","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550451577?lang=zh_cn&edition=full","pubTime":"2025-07-09 09:17","pubTimestamp":1752023845,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日,Argenx Se成交额为2.56亿美元,成交额较昨日增加11.72%,当日成交量为47.26万股。Argenx Se于2025年7月8日跌1.36%,报538.64美元,该股过去5个交易日跌2.28%,年初至今跌12.42%,过去60日跌4.52%。2022年,Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准,与Vyvgart的静脉给药相比,这是一种更方便的选择。2024年,FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变,这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709091735a43f073a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709091735a43f073a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","ARGX","BK4585","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.argenx.com","stockEarnings":[{"period":"1week","weight":-0.0394},{"period":"1month","weight":0.152},{"period":"3month","weight":0.151},{"period":"6month","weight":0.0112},{"period":"1year","weight":0.2176},{"period":"ytd","weight":0.0514}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0321},{"period":"3month","weight":0.0922},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.1897},{"period":"ytd","weight":0.1003}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Argenx Se根据荷兰法律于2008年4月25日成立,是一家私人有限责任公司(besloten vennootschap met beperkte aansprakelijkheid)。 于2014年5月28日,根据公证转换契约及修订,该公司转为上市有限责任公司(naamloze vennootschap)。 该公司是一家处于商业阶段的、全球性的、完全整合的生物制药公司,开发用于治疗严重自身免疫性疾病的差异化疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.008981},{"month":2,"riseRate":0.375,"avgChangeRate":0.041314},{"month":3,"riseRate":0.5,"avgChangeRate":-0.018965},{"month":4,"riseRate":0.75,"avgChangeRate":0.033039},{"month":5,"riseRate":0.5,"avgChangeRate":0.060079},{"month":6,"riseRate":0.777778,"avgChangeRate":0.053836},{"month":7,"riseRate":0.666667,"avgChangeRate":0.0867},{"month":8,"riseRate":0.555556,"avgChangeRate":0.006636},{"month":9,"riseRate":0.375,"avgChangeRate":-0.029368},{"month":10,"riseRate":0.625,"avgChangeRate":0.027979},{"month":11,"riseRate":0.75,"avgChangeRate":0.116645},{"month":12,"riseRate":0.5,"avgChangeRate":0.140262}],"exchange":"NASDAQ","name":"Argenx SE","nameEN":"Argenx SE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Argenx SE(ARGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Argenx SE,ARGX,Argenx SE股票,Argenx SE股票老虎,Argenx SE股票老虎国际,Argenx SE行情,Argenx SE股票行情,Argenx SE股价,Argenx SE股市,Argenx SE股票价格,Argenx SE股票交易,Argenx SE股票购买,Argenx SE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Argenx SE(ARGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}